CD4 and neoplasm: Thus, we sought to circumvent restrictions of absent HLA class II expression on tumors and the limited capacity of antigen cross-presentation of APC, by enabling CD4+ T cell to directly interact with tumor cells by introducing an MHC class I-restricted TCR.